microRNA 6831 (MIR6831)

**microRNA 6831 (MIR6831)** is a member of the microRNA (miRNA) family, a class of small, non-coding RNAs (~22 nucleotides) involved in the post-transcriptional regulation of gene expression through binding to target messenger RNAs and inhibiting translation or promoting degradation[4][5]. MIR6831 is specifically referred to as hsa-miR-6831-5p (the human, 5’-strand product). It has been identified as differentially expressed between chemosensitive and chemoresistant breast cancer patients, and is upregulated in some cancers such as bladder cancer[1]. However, there is limited information regarding its direct biological function, precise target genes, or its use as a drug target. MIR6831 has not been described as a therapeutic target (such as a receptor, enzyme, transporter, etc.), and there is no evidence it is directly targeted by approved or investigational drugs. Its main importance thus far is as a potential biomarker for cancer progression, particularly chemoresistance in breast cancer[1].\n\n**Quality & error note:** \nMIR6831 is not a classic drug target (e.g., receptor, enzyme) but instead a regulatory RNA molecule, mainly studied as a biomarker in cancer[1][4]. If you are seeking targets for drug development in the classic sense, MIR6831 is currently not regarded as such, and information about direct drug interactions, mechanism of action, or safety concerns is not available in the literature. Its sequence information and biological details may be absent from major databases, indicating either a very recent or relatively uncharacterized entry—this increases the likelihood of missing or incomplete information, and thus 'is_incorrect' is set to true for classic drug-target use.

Other names

hsa-mir-6831miR-6831hsa-miR-6831-5pmicroRNA mir-6831

Not applicable (miRNA, not a direct drug target)